Literature DB >> 26058889

T Lymphocyte Prestimulation Impairs in a Time-Dependent Manner the Capacity of Adipose Mesenchymal Stem Cells to Inhibit Proliferation: Role of Interferon γ, Poly I:C, and Tryptophan Metabolism in Restoring Adipose Mesenchymal Stem Cell Inhibitory Effect.

Pablo Mancheño-Corvo1, Ramón Menta1, Borja del Río1, Marcella Franquesa2, Cristina Ramírez1, Martin J Hoogduijn2, Olga DelaRosa1, Wilfried Dalemans3, Eleuterio Lombardo1.   

Abstract

The immunomodulatory properties of mesenchymal stem/stromal cells (MSCs) make them an attractive therapeutic tool to treat chronic inflammatory diseases, such as rheumatoid arthritis or Crohn's disease. These indications are characterized by a chronic activation of immune cells that perpetuates the disease. In vitro, when adipose mesenchymal stem cells (ASCs) are cultured with T lymphocytes at the time of stimulation, their proliferation is inhibited. However, these experimental settings do not necessarily fit with what ASCs will face in inflammatory conditions in vivo, where ASCs will likely encounter and interact with already activated immune cells which might affect their immunomodulatory capacity. In most in vitro studies, MSCs have been cultured with peripheral blood mononuclear cells at the time of lymphocyte stimulation and information about the interaction between MSCs and prestimulated lymphocytes in vitro is scarce. Therefore, a better understanding of the capacity of MSCs to modulate the responses of preactivated immune cells is needed. In this study we focused on the effects of ASCs on prestimulated lymphocytes and systematically investigated the potential mechanisms involved. We report that prestimulation of T lymphocytes 48 h before the coculture with ASCs impairs the capacity of ASCs to inhibit proliferation. Preactivation of ASCs with interferon γ or the toll-like receptor ligand Poly I:C, but not other stimuli tested, enhanced the ability to inhibit the proliferation of 48 h-stimulated T lymphocytes. The inhibitory effect of ASCs was shown to be time dependent and mediated through the actual magnitude of tryptophan degradation by indoleamine 2,3-dioxygenase.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26058889     DOI: 10.1089/scd.2014.0508

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  11 in total

Review 1.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

Review 2.  Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD.

Authors:  Bruno Sangiorgi; Rodrigo Alexandre Panepucci
Journal:  Stem Cells Int       Date:  2016-09-21       Impact factor: 5.443

3.  Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.

Authors:  Marta Monguió-Tortajada; Santiago Roura; Carolina Gálvez-Montón; Josep Maria Pujal; Gemma Aran; Lucía Sanjurjo; Marcel la Franquesa; Maria-Rosa Sarrias; Antoni Bayes-Genis; Francesc E Borràs
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

Review 4.  Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?

Authors:  Paul Lohan; Oliver Treacy; Matthew D Griffin; Thomas Ritter; Aideen E Ryan
Journal:  Front Immunol       Date:  2017-11-24       Impact factor: 7.561

5.  Functional Roles of Pattern Recognition Receptors That Recognize Virus Nucleic Acids in Human Adipose-Derived Mesenchymal Stem Cells.

Authors:  Lili Yu; Yongtao Xu; Fangchao Wang; Can Yang; Guoyan Liu; Xiangfeng Song
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

6.  Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhaolan Hu; Yanhui Cui; Xiaoqing Qiao; Xinwen He; Fang Li; Cong Luo; Shuang Wang; Changqi Li; Ruping Dai
Journal:  Front Neurosci       Date:  2018-07-10       Impact factor: 4.677

Review 7.  Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review.

Authors:  Martin J Hoogduijn; Eleuterio Lombardo
Journal:  Stem Cells Transl Med       Date:  2019-07-07       Impact factor: 6.940

8.  Effects of Normal Synovial Fluid and Interferon Gamma on Chondrogenic Capability and Immunomodulatory Potential Respectively on Equine Mesenchymal Stem Cells.

Authors:  Mohammed Zayed; Steve Adair; Madhu Dhar
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

9.  CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal Cells.

Authors:  Timo Gaber; Kerstin Schönbeck; Holger Hoff; Cam Loan Tran; Cindy Strehl; Annemarie Lang; Sarah Ohrndorf; Moritz Pfeiffenberger; Eric Röhner; Georg Matziolis; Gerd-R Burmester; Frank Buttgereit; Paula Hoff
Journal:  Int J Mol Sci       Date:  2018-08-07       Impact factor: 5.923

10.  Human cardiac stem cells inhibit lymphocyte proliferation through paracrine mechanisms that correlate with indoleamine 2,3-dioxygenase induction and activity.

Authors:  Maria J Sebastião; Ramón Menta; Margarida Serra; Itziar Palacios; Paula M Alves; Belén Sanchez; Olga DelaRosa; Wilfried Dalemans; Eleuterio Lombardo; Patrícia Gomes-Alves
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.